https://orcid.org/0000-0003-0411-8703
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Shu Hashimoto, Yuri Yoshida, Naoyuki Makita, Ryoko Sorimachi, Satoko Sugaya, Yoshifumi Arita, Nobuya Hayashi, Naoki Tashiro & Masakazu Ichinose. (2023) Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 37-46.
Read now
Read now
Masahiro Shinoda, Osamu Hataji, Motohiko Miura, Masaharu Kinoshita, Akira Mizoo, Kazunori Tobino, Toru Soutome, Takanobu Nishi, Takeo Ishii, Bruce E Miller, Ruth Tal-Singer, Ryan Tomlinson, Taizo Matsuki, Paul W Jones & Yoko Shibata. (2022) A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2931-2944.
Read now
Read now
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Josuel Ora & Maria Gabriella Matera. (2022) A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert Review of Clinical Pharmacology 15:3, pages 269-283.
Read now
Read now
Soichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, Yu Hara, Laurie A Lee, Takashi Nakayama, Jun Tamaoki, Andrew Fowler & Takanobu Nishi. (2021) Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study. Journal of Asthma and Allergy 14, pages 809-819.
Read now
Read now
Yuki Abe, Masaru Suzuki, Hiroshi Shima, Yusuke Shiraishi, Naoya Tanabe, Susumu Sato, Kaoruko Shimizu, Hirokazu Kimura, Hironi Makita, Toyohiro Hirai, Satoshi Konno & Masaharu Nishimura. (2021) Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3243-3253.
Read now
Read now
Jinping Zheng, Nanshan Zhong, Changzheng Wang, Li Ping Wei, Xiang Dong Zhou, Li Zhao, Ya Dong Yuan, Bei He, Bin Wu, Xin Du, Jie Song & David A. Lipson. (2021) Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trial. Current Medical Research and Opinion 37:1, pages 145-155.
Read now
Read now
Articles from other publishers (6)
Koichiro Takahashi, Tomotaka Kawayama, Ayako Takamori, Hiroki Tashiro, Takashi Kinoshita, Koichi Takagi, Kei Yamasaki, Kentaro Machida, Atsushi Kawaguchi, Kazuhiro Yatera & Hiromasa Inoue. (2023) Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study. BMJ Open Respiratory Research 10:1, pages e001607.
Crossref
Crossref
A.L. Aguilar-Shea & C. Gallardo-Mayo. (2022) Revisión narrativa de la terapia inhalatoria en la EPOC. Medicina de Familia. SEMERGEN 48:3, pages 214-218.
Crossref
Crossref
Chih-Cheng Lai, Chao-Hsien Chen, Kuang-Hung Chen, Cheng-Yi Wang, Tsan-Ming Huang, Ya-Hui Wang & Hao-Chien Wang. (2022) The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Life 12:2, pages 173.
Crossref
Crossref
Akira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, Naoya Fujino, Tomotaka Kawayama & Hisatoshi Sugiura. (2022) Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysis. Respiratory Investigation 60:1, pages 90-98.
Crossref
Crossref
Yuki Abe, Masaru Suzuki, Hironi Makita, Hirokazu Kimura, Kaoruko Shimizu, Satoshi Konno & Masaharu Nishimura. (2021) One‐year clinically important deterioration and long‐term clinical course in Japanese patients with COPD: a multicenter observational cohort study. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Kuniaki Hirai, Akihiko Tanaka, Tetsuya Homma, Tomoko Kawahara, Naruhito Oda, Hatsuko Mikuni, Yoshitaka Uchida, Haruhisa Saito, Yosuke Fukuda, Akiko Fujiwara, Yoko Sato, Tomoki Uno, Hideki Inoue, Shin Ohta, Fumihiro Yamaguchi, Shintaro Suzuki, Tsukasa Ohnishi & Hironori Sagara. (2021) Characteristics of and reasons for patients with chronic
obstructive pulmonary disease to continue smoking, quit
smoking, and switch to heated tobacco products. Tobacco Induced Diseases 19:November, pages 1-10.
Crossref
Crossref